Lymphoma of the Stomach

  • B.A. Dragosics


Lymphomas of the stomach mostly arise from the mucosa-associated lymphoid tissue (MALT) and represent the largest subgroup of all extranodal lymphomas. They have become a focus of interest in recent years due to their unique Helicobacter pylori (H. pylori) associated etiopathogenesis resulting in complete remission (CR) of MALT-type lymphoma in early stage in up to 80%, following cure of infection by antibiotic therapy only. Gold standard diagnostic procedures include gastro- duodenal endoscopy, tissue biopsy for histological work- up and gastric endosonography (EUS).

The outcome for patients with gastric lymphomas (GLs) is substantially more favorable than that with gastric cancer. As opposed to gastric cancer, lymphoma cells are highly sensitive towards chemotherapy (CTX) as well as irradiation (RTX) thus providing the option of a non-invasive, multimodal therapeutic approach pushing aside surgery from the first-line position. To date, both RTX and CTX have given excellent results in treating indolent as well as aggressive lymphomas, equalizing results from surgical therapy and exceeding them with respect to quality of patient life. Stage at diagnosis and the histology of the lymphoma are the most important factors predicting prognosis, which is reflected by 5-year overall survival rates between 90 and 100% for stage EI, but 50-80% for stage EII according to the Ann Arbor system and between 90% for indolent and 60% for aggressive lymphoma, respectively.

Lifelong follow up of patients in CR is recommended, because of relapses later than 10 years in other MALT locations, due to the homing properties of tumor cells and a slight increase in secondary malignancies. In the future, gastric MALT-type lymphoma may set an example for evolving molecular and cytogenetic factors into major markers predicting prognosis and selecting the mode of treatment.


Urea Breath Test Gastric Lymphoma Perigastric Lymph Node Primary Gastric Lymphoma Homing Property 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gurney KA, Cartwright RA, Gilman EA (1999) Descriptive epidemiology of gastrointestinal non-Hodgkin’s lymphoma in a population-based registry. Brit J Cancer 79:1929–1934PubMedCrossRefGoogle Scholar
  2. 2.
    Isaacson PG (1995) Primary gastric lymphoma. Brit J Biomed Science 52:291–296Google Scholar
  3. 3.
    Radaszkiewicz Th, Dragosics B, Bauer P (1992) Gastrointestinal Malignant Lymphomas of the Mucosa-Associated Lymphoid Tissue: Factors Relevant to Prognosis. Gastroenterology 102:1628–1638PubMedGoogle Scholar
  4. 4.
    Fischbach W, Dragosics B, Kolve-Goebeler ME, et al. (2000) Primary gastric B-cell lymphoma: results of a multicenter study. Gastroenterology 119:1191–1202PubMedCrossRefGoogle Scholar
  5. 5.
    Ruskone-Fourmestraux A, Lavergne A, Aegerter Ph (2001) Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 48:297–303PubMedCrossRefGoogle Scholar
  6. 6.
    Jaffe E, Harris N, Diebold J, Mül ler-Hermelink H (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: A progress report. Am J Clin Pathol 111(Suppl) S8–S12PubMedGoogle Scholar
  7. 7.
    De Jong D, Boot H, Van Heerde P, Hart GAM, Taal BG (1997) Histological Grading in Gastric Lymphoma: Pretreatment Criteria and Clinical Relevance. Gastroenterology 112:1466–147PubMedCrossRefGoogle Scholar
  8. 8.
    Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Feimann P, Salles G, Coifiier B (2000) Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 95(3): 802–806PubMedGoogle Scholar
  9. 9.
    Morgner A, Miehlke S, Fischbach W, Schmitt W, Mül ler-Hermelink HK (2001) Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol 19: 2041–8PubMedGoogle Scholar
  10. 10.
    Ruskone-Fourmestraux A, Aegerter Ph, Delmer A, et al. (1993) Primary digestive tract lymphoma: a prospective multicentric study of 91 patients. Gastroenterology 105:1662–1671PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • B.A. Dragosics
    • 1
  1. 1.Wiener Gebietskrankenkasse, Gesundheitszentrum Wien SüdWienAustria

Personalised recommendations